£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Acute Agitation Aggression Treatments Outlook China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study examines the latent demand outlook for acute agitation and aggression treatments across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions, and Taiwan. The analysis provides potential industry earnings (P.I.E.) estimates across approximately 1,100 Chinese cities, offering detailed market sizing and regional demand forecasts. Ideal for healthcare investors, pharmaceutical companies, and market strategists seeking data-driven insights into China's mental health treatment sector through 2028.

Key Features

Covers latent demand outlook for acute agitation and aggression treatments across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions.

Provides potential industry earnings (P.I.E.) estimates for approximately 1,100 cities across China to support investment and expansion decisions.

Includes detailed market analysis for major cities with regional share percentages to identify high-opportunity markets for treatment providers.

Forecasts market trends and demand patterns from 2023 through 2028 to guide long-term strategic planning in China's healthcare sector.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

2023-2028 Hypercalcemia Treatment Outlook for China
89% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
87% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
2023-2028 Card Payment ATM Transactions Outlook China
87% match

2023-2028 Card Payment ATM Transactions Outlook China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States
87% match

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Feminine Hygiene Products Outlook - China Market Report
87% match

2023-2028 Feminine Hygiene Products Outlook - China Market Report

£495.00 28 Sep 2026
2023-2028 Facial Care Products Outlook for China - Market Analysis
87% match

2023-2028 Facial Care Products Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
87% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
2023-2028 Mycotoxin Binders Outlook for China - Market Analysis
86% match

2023-2028 Mycotoxin Binders Outlook for China - Market Analysis

£495.00 28 Sep 2026
The 2019-2024 Outlook for Antibody Drugs in China
86% match

The 2019-2024 Outlook for Antibody Drugs in China

£446.25 27 Sep 2026
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
86% match

The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Peripheral Neuropathy Treatments for US Zip Codes
86% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
86% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
86% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
86% match

China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook

£495.00 28 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
86% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes
86% match

The 2023-2028 Outlook for Pain Management Therapeutics for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
86% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Atrophic Scars Treatments for US Zip Codes
86% match

The 2023-2028 Outlook for Atrophic Scars Treatments for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
86% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
86% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States
86% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hypercalcemia Treatments in India
86% match

The 2023-2028 Outlook for Hypercalcemia Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in India
86% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Immune-Oncology Treatments in India
86% match

The 2023-2028 Outlook for Immune-Oncology Treatments in India

£515.00 27 Sep 2026